investor relations

nanotype just obtained a seed investment from Munich Biotech Development Bio-M AG.

The seed financing will carry the biotech start-up company through
- completion the proof-of-principle
- patenting of basic concepts
- building of a core team

A first Venture Capital financing round is planned for the first quarter of 2001. Additional information can be obtained from the companies managing director Gunnar Brink.